Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Biogen to Present Additional Results from Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus at ACR Convergence 2025
-
FinWise Bancorp Announces Strategic Program Agreement with DreamFi, Inc. to Provide Financial Products that Empower Underbanked Communities to Build Financial Stability
-
Saia Announces Retirement of CIO Rohit Lal and Appointment of Successor Tarak Patel
-
POET Technologies Receives $5 Million Production Order for 800G Optical Engines
-
Appili Therapeutics to Attend BARDA Innovation Symposium 2025
-
Nurix Therapeutics Announces $250.0 Million Registered Offering of Common Stock
-
Gilat to Report Third Quarter 2025 Results on Wednesday, November 12th
-
Mutuum Finance (MUTM) Completes Phase 1 of Roadmap, Begins Development of DeFi Lending Protocol
-
Old National Bancorp Reports Third Quarter 2025 Results
-
Marex Group plc to acquire European fixed income market maker Valcourt SA
-
Atlas Warehouse Lending Company Recapitalized to Strengthen Investment-Grade Credit Profile and Expand Lending Capacity
-
Atea Pharmaceuticals to Host Virtual HCV KOL Panel Event on November 13, 2025
-
Presenting on Emerging Growth Conference 87 Day 2 on October 23; Register to live stream
-
Fidelity D & D Bancorp, Inc. Reports Third Quarter 2025 Financial Results
-
Mercury Awarded Contract To Develop Multi-Mission Subsystem for U.S. Military Programs
-
Electra Therapeutics Announces First Patients Dosed in the SURPASS Phase 2/3 Pivotal Study of ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
-
Stifel Reports Third Quarter 2025 Results
-
Troilus Announces Change of Auditor
-
Tonix Pharmaceuticals Announces First Patient Dosed in the Investigator-Initiated FOCUS Study of Tonix’s Intranasal Potentiated Oxytocin in AVP-D Conducted by Massachusetts General Hospital
-
Village Farms Introduces Industry-First, One-Way Aroma Valve in Cannabis Packaging
-
Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
-
Electra Therapeutics Receives FDA Breakthrough Therapy and EMA Priority Medicines Designations for ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
-
Electra Therapeutics Announces $183 Million Series C Financing to Advance First-in-Class SIRP-Targeted Therapies for Immune Disorders and Cancer
-
T1 Energy Announces Preliminary Results for Third Quarter 2025
-
Curanex Pharmaceuticals Inc. Engages Strategic Investor Relations to Enhance Investor Communications and Engagement
-
Mobix Labs Wins Multi-Year U.S. Navy Follow-On Contract as Company Accelerates Growth in Defense and High-Tech Markets
-
Winnebago Industries Reports Fourth Quarter and Full Year Fiscal 2025 Results
-
Troilus Announces Change of Auditor
-
Enthusiast Gaming Provides Update Regarding Annual General and Special Meeting of Shareholders
-
As Companies Clamor to Adopt AI, Culture and Trust Dictates Success, Says New “AI for All Index™” from UKG’s Great Place To Work
-
Axsome Therapeutics to Participate in Upcoming Investor Conferences
-
OTC Markets Group Welcomes Aviva PLC to OTCQX
-
Dorman’s Complex Electronic Solutions Portfolio Expands With OE FIX® EPS Rack for Ram Trucks
-
ECARX and Victory Giant Technology Announce Global Strategic Partnership
-
Vema Hydrogen to Help Power California's Clean Energy Transition as a Qualified FPH2 Supplier
-
B2PRIME Welcomes Emanuel Georgouras as CRO to Drive Institutional Growth and Revenue Strategy
-
Steve Madden Announces Third Quarter 2025 Earnings Release Date
-
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
-
RentRedi Launches Alerts That Help Landlords Proactively Plan Renewals and Reduce Vacancies
-
Bad Credit Borrowers Secure 87% Approval Rate Through AI Loan Matching: RadCred Study Reveals
-
Third Party Logistics Provider CPGIO Uses Descartes’ Ecommerce Inventory and Order Management Solution to Achieve 5x Growth
-
BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings Inc
-
Man Group PLC : Form 8.3 - Spectris plc
-
Avadel Pharmaceuticals and Jazz Pharmaceuticals Reach Global Settlement
-
PatientSync Selects Telnyx to Power AI-Driven Voice Experiences for Healthcare Enterprises
-
Form 8.3 - [NCC GROUP PLC - 21 10 2025] - (CGAML)
-
Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays
-
JASCAYD® (nerandomilast) approved in China for the treatment of idiopathic pulmonary fibrosis (IPF)
